Neopenda innovates needs-based medical technologies for high-growth emerging markets.
Neopenda has raised $200K in total funding. The most recent round was Debt Financing. The last funding was announced in November 2024.
Neopenda's investors include Techstars, 54 Collective, MassChallenge, Connetic Ventures, Sorenson Impact Foundation.
Neopenda is headquartered in Chicago, United States.
Neopenda innovates needs-based medical technologies for high-growth emerging markets.
Neopenda is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neopenda — Funding & Investors." VCBacked, November 18, 2024, https://www.vcbacked.co/company/neopenda. Accessed September 15, 2026.
VCBacked. (2024). Neopenda — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/neopenda
{{cite web |title=Neopenda — Funding & Investors |url=https://www.vcbacked.co/company/neopenda |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated